
My Gen Z son commits a hate crime every time he makes a cuppa… and he's not alone
My 16-year-old Gen Z son, Charlie, uses the microwave for everything, including – shock horror – making a cup of tea. And, according to a new survey, he is not alone.
Apparently, almost two-thirds of under-30s make tea in the microwave, a Uswitch poll of 2,000 Brits has shown. Why Gen Zs – that baffling and unknowable generation born between 1997 and 2012 – are kettle-dodgers who would rather pop a teabag in a mug of cold water and heat it in the mee-cro-wah-vey, as Nigella Lawson rechristened it, defeats me.
It's clearly not about saving time or effort. 'Microwave heating can produce uneven temperature,' says Dr Tim Bond from the Tea Advisory Panel. He also advises that 'heating a mug of water in a microwave takes about two minutes and 40 seconds – significantly longer than the 48 seconds required to boil the same volume in a kettle.' Even longer than that if, like my son, they use one of those hideous, oversized Sports Direct mugs.
And it's not a taste thing either: a microwaved brew is 'flat, with a stewed flavour,' says Dr Bond, and offers 'inconsistent extraction of tea bioactives, which are packed with health and wellness benefits '. So it's not better for you.
We've heard the debates about whether to put milk in first or last (last, obviously), but for Gen Z, the only question is how long to put it all in the microwave for.
My son says he worries that the kettle might become too hot to use and, in his words, 'overboil'. The microwave is, he thinks, a safer bet. I haven't the energy to tell him how microwaved water can become 'superheated' and bubble over the moment the cup is moved.
I can't help thinking that microwaving tea is less a TikTok craze (though American influencers went through a phase of filming themselves 'making an English cuppa' in this way) or another small act of Gen Z rebellion, and more a case of kettle-phobia.
When Charlie was eight, I left him and his siblings in the care of my Boomer dad. Charlie burned his hand on the hob and has been a bit wary around kitchen appliances, including the kettle, ever since. And yet he will quite happily blast the Nutribullet multiple times a day to make protein shakes…
I can certainly attest to how revolting a microwaved brew is. One Mother's Day, my kids sweetly offered to make me breakfast in bed. Alongside some charred toast with a great dollop of butter was a mug of what looked like taupe-coloured sludge, the teabag floating at the top. Yuck.
'Looks lovely, thanks, darlings,' I said before nipping discreetly to the loo to chuck it away.
I remember a time when I had three kids under five and rarely got to finish a hot cuppa, so would quite often use the microwave to reheat my tea – but only after I'd made it properly first. I once found a mug in the microwave which had obviously been festering there for several days.
Experts say the best way to make a cup of tea is to pour boiling water over a teabag and leave it to steep for three to five minutes without stirring, before adding a splash of milk.
I hope that, in time, my kids will see sense and that they will never subject my mother-in-law to a microwaved brew. I can only imagine how horrified she would be. She would probably spit it right out of her china cup.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Independent
26 minutes ago
- The Independent
GSK to be paid up to £370 million after patent row settles in US
Drug maker GSK has secured a payment of up to 500 million dollars (£372 million) after a patent row over Covid vaccines was settled in the US. GSK told investors it will receive a 370 million dollar (£275 million) settlement from CureVac, which it had worked with on the development of mRNA vaccine technology. The London-based business will then be entitled to receive an additional 130 million dollars (£97 million) depending on if a planned takeover of CureVac by BioNTech closes, which would settle a lawsuit outside of the US. CureVac – a German pharmaceutical company – settled a long-running patent dispute with rival BioNTech and Pfizer in the US on Thursday. Drug makers had launched several lawsuits over alleged patent infringement in relation to their Covid-19 vaccines. CureVac said that, under the terms of the settlement, it would grant BioNTech and Pfizer a licence to make, use, and sell mRNA-based Covid and influenza jabs. The firms also agreed that GSK would take 1% of the royalties from the vaccine sales in the US from the beginning of 2025. The cash payment to GSK stems from its partnership with CureVac which was first struck in 2020. GSK remains in dispute with Pfizer and BioNTech in the US and Europe over alleged infringement of its own patents. Shares in GSK rose by as much as 1.7% on Friday morning. Danni Hewson, head of financial analysis for AJ Bell, said: 'Pharmaceutical giant GSK was also among the gainers on Friday morning as it secured a positive outcome from the settlement of a patent dispute involving CureVac with which it has a licence agreement. 'The dispute related to mRNA vaccines and gives GSK a modest, though still welcome, cash injection and the prospect of sales royalties.'


The Guardian
27 minutes ago
- The Guardian
Bidding battle for NHS landlord Assura intensifies as watchdog steps up investigation
The bidding battle for the NHS landlord Assura has heated up after its US suitor KKR lobbied the board to accept its offer, while the competition watchdog stepped up its investigation of Assura's £1.79bn takeover by a rival UK healthcare investor. Primary Health Properties (PHP), which invests in buildings housing GP practices, has been blocked from fully integrating Assura by the Competition and Markets Authority while it looks into the takeover. The watchdog said it had served an initial enforcement order on the companies, after launching an investigation into the takeover last month to determine whether the deal would 'result in a substantial lessening of competition'. PHP won backing from Assura's board in June for the acquisition, after a lengthy bidding war with the New York-based private equity firm KKR. Assura, which was founded in Altrincham in Greater Manchester in 2003, has a market value of £1.6bn. Last August it struck a £500m deal with a Canadian investor to buy 14 private hospitals across the UK, including Cancer Centre London and the Edgbaston hospital in Birmingham. Assura has been buying healthcare properties at a time when the NHS remains under immense pressure to reduce long waiting times for operations and other treatments. It emerged on Friday that KKR has urged Assura's board to back its takeover bid and withdraw its support for PHP's offer. KKR, which is leading the bid with Stonepeak Partners, said it had met the board of Assura in recent days to lobby for its own cash takeover of the company. KKR and PHP were locked in a takeover battle for Assura for months before Assura's board backed PHP's higher bid in June. The US private equity firm argues that a number of factors have changed since Assura threw its support behind PHP's offer, including a decline in the share price of both companies, which it said had raised the premium of its own cash offer. Assura owns 603 properties housing GP practices and hospitals in the UK, which serve more than 6 million patients, and many of which are rented to the NHS. They were valued at £3.1bn at the end of March, up from £2.7bn the year before. Sign up to Business Today Get set for the working day – we'll point you to all the business news and analysis you need every morning after newsletter promotion Its rental income climbed by 16.6% to £167m during the year, as the company raised its rents by 3.2%. This meant it moved into the black with a pre-tax profit of £166m, against a loss of £28.7m the year before. PHP owns 516 properties housing GPs in the UK and Ireland valued at £2.8bn, and made £153.6m in rental income last year. In early June, KKR pulled out of a deal to inject fresh equity into Thames Water, leaving the troubled supplier's future in doubt and increasing the prospects of a temporary nationalisation.


Daily Mail
an hour ago
- Daily Mail
Kenny Logan bravely reveals his sex life struggles with wife Gabby (and what he keeps private in the bedroom) after he had his prostate removed following cancer battle
Kenny Logan has bravely revealed his sex life struggles with wife Gabby to raise awareness for men who have also had their prostate removed. Former Scottish rugby international Kenny, 53, was diagnosed with cancer in February 2022 after Gabby, 52, urged him to go to the doctors. In a candid chat with the Telegraph, Kenny shared erections became 'impossible' during his cancer battle which he feared would take a toll on their sex life. He said: 'I was forewarned that prostatectomy meant that, at least for a while, getting erections would be impossible. That's a huge deal for any man.' 'I never allowed myself to stress "what if they never come back". Instead, I focused on being fit and cancer-free, I'm relentlessly positive. After about three months, I was relieved to have some movement down there. 'When it came to sex, things were 'inconsistent' let's say, for a good three months [after that].' Kenny also explained he used a 'penis pump' to to stimulate an erection, which he insists on keeping private in the bedroom. Vacuum pumps encourage blood to flow to the penis, causing an erection. They work for most men and can be used if medicine is not suitable or does not work, as per the NHS. He said: 'It's certainly not sexy... I used it for 10 minutes a day or so, several times in that first month, grateful Gabby was away working on the Commonwealth Games. 'I warned her that if she ever walked in on me using it and didn't back straight out the door, I'd never speak to her again! Some things are private, even in marriage.' Kenny and presenter Gabby have been married for over 22 years and share two children together. In February 2023, Kenny spoke candidly about the after-effects of treatment, and said they left him 'black and blue downstairs'. Speaking to The Telegraph at the time, he said: 'Whether it be my dyslexia, my relationship, IVF, we've always been quite open. So, I was quite happy to talk about erectile dysfunction and all these other things because I was like, "It is a symptom".' 'From a sexual point of view, it's not consistent. As the surgeon said to me, this could take 18 months. 'Within a month, I was getting movement, where he says, "That's amazing". So it's just not as consistent. The beauty is you can take a tablet and it changes things.' He explained that his brave honesty was motivated by his desire to help other people. Reiterating the need for all men his age to get checked, he said: 'If I can help one person, that'd be great. But I've probably helped a lot of people with the coverage it had.' The couple said Kenny was 'extremely lucky' they caught it early, which afforded him options regarding treatment. Kenny was inspired to go for a general check up after hearing guests on his wife's podcast discuss having their hormones tested. And when he did his results showed a high level of PSA - prostate-specific antigen. 'I got checked and very quickly, within three to four months, I had a biopsy and they said there was something there but they'd keep an eye on it,' he said. He said what stood out the most from that appointment was the specialist telling him '40 per cent of [his] mates have got this [high PSA levels] but don't know'. It doesn't always lead to cancer and many men go their entire lives not knowing. So when he was diagnosed with prostate cancer a short time later, Kenny recalled it being 'a huge shock'. He made the decision to remove the prostate entirely and is now three months post operation feeling almost as good as new. 'I'm probably about 90 per cent back to normal,' he said. Prostate cancer can often be treated if caught early, but symptoms usually do not show up until the cancer is already in advanced states. It is the most common cancer in men in the UK. The couple are encouraging men to learn more about the disease and consider talking to their GP about the risks. Every year, upwards of 52,300 men are diagnosed with prostate cancer in the UK - more than 140 every day. Up to 11,800 men in Britain die from prostate cancer annually, meaning it trails only lung and bowel cancer in yearly fatalities. WHAT IS PROSTATE CANCER? How many people does it kill? More than 11,800 men a year - or one every 45 minutes - are killed by the disease in Britain, compared with about 11,400 women dying of breast cancer. It means prostate cancer is behind only lung and bowel in terms of how many people it kills in Britain. In the US, the disease kills 26,000 men each year. Despite this, it receives less than half the research funding of breast cancer and treatments for the disease are trailing at least a decade behind. How many men are diagnosed annually? Every year, upwards of 52,300 men are diagnosed with prostate cancer in the UK - more than 140 every day. How quickly does it develop? Prostate cancer usually develops slowly, so there may be no signs someone has it for many years, according to the NHS. If the cancer is at an early stage and not causing symptoms, a policy of 'watchful waiting' or 'active surveillance' may be adopted. Some patients can be cured if the disease is treated in the early stages. But if it is diagnosed at a later stage, when it has spread, then it becomes terminal and treatment revolves around relieving symptoms. Thousands of men are put off seeking a diagnosis because of the known side effects from treatment, including erectile dysfunction. Tests and treatment Tests for prostate cancer are haphazard, with accurate tools only just beginning to emerge. There is no national prostate screening programme as for years the tests have been too inaccurate. Doctors struggle to distinguish between aggressive and less serious tumours, making it hard to decide on treatment. Men over 50 are eligible for a 'PSA' blood test which gives doctors a rough idea of whether a patient is at risk. But it is unreliable. Patients who get a positive result are usually given a biopsy which is also not fool-proof. Scientists are unsure as to what causes prostate cancer, but age, obesity and a lack of exercise are known risks. Anyone with any concerns can speak to Prostate Cancer UK's specialist nurses on 0800 074 8383 or visit